Glioblastoma with Oligodendroglioma Component (GBM‐O): Molecular Genetic and Clinical Characteristics

Glioblastoma (GBM) is an aggressive primary brain tumor with an average survival of approximately 1 year. A recently recognized subtype, glioblastoma with oligodendroglioma component (GBM‐O), was designated by the World Health Organization (WHO) in 2007. We investigated GBM‐Os for their clinical and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain Pathol
Principais autores: Appin, Christina L., Gao, Jingjing, Chisolm, Candace, Torian, Mike, Alexis, Dianne, Vincentelli, Cristina, Schniederjan, Matthew J., Hadjipanayis, Costas, Olson, Jeffrey J., Hunter, Stephen, Hao, Chunhai, Brat, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2013
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868066/
https://ncbi.nlm.nih.gov/pubmed/23289977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados